Related Experiment Video
Updated: May 8, 2026
10:23
Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
Published on: November 4, 2022
Human kidney cell reprogramming: applications for disease modeling and personalized medicine
Adam C O'Neill1, Sharon D Ricardo
1Department of Pediatrics, Dunedin School of Medicine, Otago University, New Zealand.
Journal of the American Society of Nephrology : JASN
|August 17, 2013
Summary
Induced pluripotent stem cells (iPSCs) offer exciting potential for modeling kidney diseases. This review explores how iPSCs could advance renal medicine through disease modeling and cell-replacement therapies.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Nephrology
Background:
- Induced pluripotent stem cells (iPSCs) are reprogrammed cells with embryonic stem cell-like properties.
- iPSC technology has significantly impacted disease modeling and therapeutic potential in neuroscience and cardiology.
- Renal medicine has yet to fully leverage the advancements offered by iPSC technology.
Purpose of the Study:
- To review the unique characteristics of iPSCs.
- To explore the potential applications of iPSCs in modeling kidney diseases.
- To highlight the prospective benefits for renal medicine.
Main Methods:
- Literature review of iPSC technology and its applications.
- Analysis of iPSC potential for renal disease modeling.
- Discussion of therapeutic implications in nephrology.
Main Results:
- iPSCs possess unique characteristics suitable for disease modeling.
- Applications include recapitulating kidney disease phenotypes.
- Potential for targeted drug development and cell-based therapies.
Conclusions:
- iPSC technology holds significant promise for advancing renal medicine.
- Future endeavors could lead to novel disease models and treatments for kidney diseases.
- iPSCs may provide replenishable sources for kidney cell replacement therapy.
More Related Videos
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...